| Bos taurus |
Phenylethanolamine N-methyltransferase |
Ki |
740000.0 |
nM |
10.1021/jm00352a020 |
| Bos taurus |
Phenylethanolamine N-methyltransferase |
Ki |
740000.0 |
nM |
10.1021/jm00352a021 |
| Bos taurus |
Phenylethanolamine N-methyltransferase |
Ki |
740000.0 |
nM |
10.1021/jm00352a031 |
| Gerbillinae |
Gerbillinae |
Activity |
nan |
None |
10.1016/j.bmc.2013.02.010 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
17999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
10999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-3 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
AC50 |
300000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Carbonic anhydrase I |
Ka |
150.0 |
uM |
10.1016/j.ejmech.2022.114828 |
| Homo sapiens |
Carbonic anhydrase II |
Ka |
150.0 |
uM |
10.1016/j.ejmech.2022.114828 |
| Homo sapiens |
Carbonic anhydrase III |
Ka |
87.7 |
uM |
10.1016/j.ejmech.2022.114828 |
| Homo sapiens |
Carbonic anhydrase IV |
Ka |
0.094 |
uM |
10.1016/j.ejmech.2022.114828 |
| Homo sapiens |
Carbonic anhydrase IX |
Ka |
150.0 |
uM |
10.1016/j.ejmech.2022.114828 |
| Homo sapiens |
Carbonic anhydrase VA |
Ka |
0.81 |
uM |
10.1016/j.ejmech.2022.114828 |
| Homo sapiens |
Carbonic anhydrase VB |
Ka |
2.56 |
uM |
10.1016/j.ejmech.2022.114828 |
| Homo sapiens |
Carbonic anhydrase VI |
Ka |
150.0 |
uM |
10.1016/j.ejmech.2022.114828 |
| Homo sapiens |
Carbonic anhydrase VII |
Ka |
0.91 |
uM |
10.1016/j.ejmech.2022.114828 |
| Homo sapiens |
Carbonic anhydrase XII |
Ka |
0.64 |
uM |
10.1016/j.ejmech.2022.114828 |
| Homo sapiens |
Carbonic anhydrase XIII |
Ka |
24.1 |
uM |
10.1016/j.ejmech.2022.114828 |
| Homo sapiens |
Carbonic anhydrase XIV |
Ka |
9.15 |
uM |
10.1016/j.ejmech.2022.114828 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
3500.0 |
nM |
10.1021/jm049536b |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-B |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor beta |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gastric inhibitory polypeptide receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucagon receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
0.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neurotensin receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
8840.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Affinity |
nan |
None |
10.1021/jm00144a009 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Skin |
log Kp |
-8.21 |
None |
10.1016/j.bmc.2007.07.050 |
| Homo sapiens |
Solute carrier family 22 member 5 |
Activity |
nan |
None |
10.1006/bbrc.1998.8669 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Whole blood |
Retention_time |
2.6 |
min |
10.1007/s00044-012-9977-1 |
| Mus musculus |
Cytochrome P450 2A5 |
IC50 |
2850.0 |
nM |
10.1021/jm049536b |
| Mus musculus |
Mus musculus |
Activity |
177.0 |
None |
10.1021/jm00343a010 |
| Mus musculus |
Mus musculus |
Activity |
562.0 |
None |
10.1021/jm00343a010 |
| Mus musculus |
Mus musculus |
Activity |
993.0 |
None |
10.1021/jm00343a010 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/acs.jmedchem.5b00115 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/jm00199a014 |
| Mus musculus |
Mus musculus |
ED50 |
1.6 |
mg.kg-1 |
10.1021/jm00355a012 |
| Mus musculus |
Mus musculus |
ED50 |
27.0 |
umol.kg-1 |
10.1021/jm00199a014 |
| Mus musculus |
Mus musculus |
ED50 |
44.0 |
umol.kg-1 |
10.1021/jm00199a014 |
| Mus musculus |
Mus musculus |
ED50 |
60.0 |
umol.kg-1 |
10.1021/jm00199a014 |
| Mus musculus |
Mus musculus |
ED50 |
100.0 |
umol.kg-1 |
10.1021/jm00199a014 |
| Mus musculus |
Mus musculus |
Inhibition |
0.0 |
% |
10.1021/jm00199a014 |
| Mus musculus |
Mus musculus |
Net turns/min |
5.5 |
None |
10.1021/jm00343a010 |
| Mus musculus |
Mus musculus |
Retention |
35.0 |
% |
10.1021/jm00135a020 |
| Mus musculus |
Mus musculus |
Retention |
70.0 |
% |
10.1021/jm00135a020 |
| Mus musculus |
Mus musculus |
Retention |
75.0 |
% |
10.1021/jm00135a020 |
| Mus musculus |
Mus musculus |
Retention |
90.0 |
% |
10.1021/jm00135a020 |
| Mus musculus |
Norepinephrine transporter |
IC50 |
1000.0 |
nM |
10.1021/jm00199a014 |
| Mus musculus |
Serotonin transporter |
IC50 |
45000.0 |
nM |
10.1021/jm00199a014 |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
Relative activity |
1.3 |
None |
10.1021/jm00144a009 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Dopamine transporter |
IC50 |
960.0 |
nM |
10.1021/jm00227a030 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
10.0 |
% |
10.1021/np50004a007 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1021/jm00207a005 |
| Rattus norvegicus |
Rattus norvegicus |
DOM |
2.0 |
% |
10.1021/jm00352a013 |
| Rattus norvegicus |
Rattus norvegicus |
DOM |
26.0 |
% |
10.1021/jm00352a013 |
| Rattus norvegicus |
Rattus norvegicus |
DOM |
nan |
None |
10.1021/jm00352a013 |
| Rattus norvegicus |
Rattus norvegicus |
DOSE |
6.25 |
mg.kg-1 |
10.1021/jm00355a012 |
| Rattus norvegicus |
Rattus norvegicus |
DOSE |
12.5 |
mg.kg-1 |
10.1021/jm00355a012 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
2.1 |
mg.kg-1 |
10.1021/jm00355a012 |
| Rattus norvegicus |
Rattus norvegicus |
No. of animals |
0.0 |
None |
10.1021/jm00352a013 |
| Rattus norvegicus |
Rattus norvegicus |
No. of animals |
1.0 |
None |
10.1021/jm00352a013 |
| Rattus norvegicus |
Rattus norvegicus |
No. of animals |
3.0 |
None |
10.1021/jm00352a013 |
| Rattus norvegicus |
Rattus norvegicus |
No. of animals |
5.0 |
None |
10.1021/jm00352a013 |
| Rattus norvegicus |
Serotonin 1 (5-HT1) receptor |
Ki |
7660.0 |
nM |
10.1021/jm00152a005 |
| Rattus norvegicus |
Serotonin 1 (5-HT1) receptor |
Ki |
7660.0 |
nM |
10.1021/jm00384a001 |
| Rattus norvegicus |
Serotonin 2 (5-HT2) receptor |
Ki |
10000.0 |
nM |
10.1021/jm00082a014 |
| Rattus norvegicus |
Serotonin 2 (5-HT2) receptor |
Ki |
43000.0 |
nM |
10.1021/jm00152a005 |
| Rattus norvegicus |
Serotonin 2 (5-HT2) receptor |
Ki |
43000.0 |
nM |
10.1021/jm00384a001 |
| Rattus norvegicus |
Serotonin 2a (5-HT2a) receptor |
Ki |
10000.0 |
nM |
10.1021/acs.jmedchem.7b00085 |
| Rattus norvegicus |
Serotonin 2a (5-HT2a) receptor |
Ki |
10000.0 |
nM |
10.1021/jm9906062 |
| Rattus norvegicus |
Serotonin 2b (5-HT2b) receptor |
Kd |
5370.32 |
nM |
10.1021/jm00144a009 |
| Rattus norvegicus |
Serotonin 2c (5-HT2c) receptor |
Ki |
10000.0 |
nM |
10.1021/jm00082a014 |
| Rattus norvegicus |
Serotonin 2c (5-HT2c) receptor |
Ki |
10000.0 |
nM |
10.1021/jm9906062 |
| Rattus norvegicus |
Serotonin (5-HT) receptor |
Kd |
5370.32 |
nM |
10.1021/jm00177a017 |
| Rattus norvegicus |
Serotonin (5-HT) receptor |
Kd |
5370.32 |
nM |
10.1021/jm00346a012 |
| Rattus norvegicus |
Serotonin (5-HT) receptor |
Kd |
5370.32 |
nM |
10.1021/jm00352a013 |
| Rattus norvegicus |
Sigma opioid receptor |
Ki |
50000.0 |
nM |
10.1021/jm00107a033 |
| Rattus norvegicus |
Solute carrier family 22 member 3 |
IC50 |
42000.0 |
nM |
10.1074/jbc.273.49.32776 |
| Rattus norvegicus |
Solute carrier family 22 member 5 |
Inhibition |
nan |
% |
None |
| Rattus norvegicus |
Transporter |
IC50 |
200.0 |
nM |
10.1021/jm00227a030 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Voltage-gated N-type calcium channel alpha-1B subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| None |
ADMET |
Activity |
nan |
None |
10.1016/j.ejmech.2022.114828 |
| None |
ADMET |
Binding energy |
6.8 |
kCal mol-1 |
10.1021/jm00378a021 |
| None |
ADMET |
CL |
9.7 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
MRT |
10.0 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Selectivity ratio |
20.0 |
None |
10.1124/dmd.112.044875 |
| None |
ADMET |
T1/2 |
7.3 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
6.1 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
NON-PROTEIN TARGET |
Fu |
0.8 |
None |
10.1124/dmd.108.020479 |
| None |
No relevant target |
LogP |
1.63 |
None |
10.1021/jm00144a009 |
| None |
No relevant target |
Log PNalk |
0.73 |
None |
10.1021/jm048980b |
| None |
No relevant target |
Solubility |
500000.0 |
nM |
10.1016/j.bmcl.2010.10.068 |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1080/15376510701857262 |
| None |
Unchecked |
IC50 |
1288249.55 |
nM |
10.1021/jm00214a001 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1021/jm400046q |
| None |
Unchecked |
KDNB |
0.55 |
None |
10.1021/jm00144a009 |
| None |
Unchecked |
T1/2 |
0.81 |
hr |
10.1021/jm400046q |
| None |
Unchecked |
TIME |
0.37 |
hr |
10.1016/j.ejmech.2020.112405 |